| Erica Lynn Gemme, PA-C | |
|
1493 Cambridge St, Cambridge, MA 02139-1047 | |
| (617) 665-1000 | |
| Not Available |
| Full Name | Erica Lynn Gemme |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 1493 Cambridge St, Cambridge, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093361222 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | (* (Not Available)) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cambridge Public Health Commission | 8921910894 | 536 |
News Archive
Unequal progress in achieving U.N. Millennium Development Goals (MDGs) for tuberculosis and child mortality in low-income countries is related to the countries' burdens of HIV and non-communicable diseases (NCD), according to a study published Tuesday in the journal PLoS Medicine, Reuters reports (Kelland, 3/2).
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
The 2021 MJA–Lancet Countdown report represents a collaborative effort between University College London, and seven Australian institutions, mediated by The Lancet in partnership with The Medical Journal of Australia.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erica Lynn Gemme, PA-C 1493 Cambridge St, Cambridge, MA 02139-1047 Ph: (508) 864-0643 | Erica Lynn Gemme, PA-C 1493 Cambridge St, Cambridge, MA 02139-1047 Ph: (617) 665-1000 |
News Archive
Unequal progress in achieving U.N. Millennium Development Goals (MDGs) for tuberculosis and child mortality in low-income countries is related to the countries' burdens of HIV and non-communicable diseases (NCD), according to a study published Tuesday in the journal PLoS Medicine, Reuters reports (Kelland, 3/2).
A late-breaking clinical trial, known as the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist trial, to be presented at the American Heart Association Scientific Sessions, November 18, 2013, demonstrates that spironolactone did not reduce the primary outcome of cardiovascular death, heart failure hospitalization, nor surviving a cardiac arrest in patients with heart failure and preserved ejection fraction (pump function). However, spironolactone did reduce the major burden faced by these patients-the risk of repeated hospitalizations for heart failure.
The 2021 MJA–Lancet Countdown report represents a collaborative effort between University College London, and seven Australian institutions, mediated by The Lancet in partnership with The Medical Journal of Australia.
ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company that is developing immune based therapies for the treatment of brain and other cancers, announced today that it will participate in the Southern California Investor Conference being held in Newport Beach, CA, on Tuesday August 18, 2009.
Breast Cancer Action - respected watchdog of the breast cancer movement - is calling out money-making giants KFC and Susan G. Komen for the Cure for their egregious pinkwashing campaign "Buckets for the Cure." This partnership exploits breast cancer and does the most harm in low income communities already disproportionately affected by health issues like obesity, diabetes, as well as breast cancer.
› Verified 9 days ago
Elizabeth Steinheider, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1566 | |
Michael George Crace, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1000 | |
Taia Maria Tieland, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 9 Hunting St Apt 1, Cambridge, MA 02141 Phone: 603-845-7787 | |
Miss Catherine Laura Spruance, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1493 Cambridge St, Cambridge, MA 02139 Phone: 617-665-1430 | |
Ms. Nyaradzo Prisca Munjanja, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1400 Cambridge St, Cambridge, MA 02139 Phone: 617-714-4534 Fax: 617-714-4962 | |
Mr. Shawn Reap, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 330 Mount Auburn St, Cambridge, MA 02138 Phone: 617-492-3500 | |
Bronwyn Kate Mastrangelo, Physician Assistant Medicare: Medicare Enrolled Practice Location: 1611 Cambridge St, Cambridge, MA 02138 Phone: 617-661-5500 |